Skip main navigation
Close Drawer MenuOpen Drawer Menu
APA Publishing Logo

The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Back to table of contents
Clinical & Research NewsFull Access

Buprenorphine Course in New York

Published Online:16 Apr 2004https://doi.org/10.1176/pn.39.8.0070a

Psychiatrists who want to be certified for prescribing office-based buprenorphine therapy for opiate addiction may want to register on site for a CME course being offered at APA’s 2004 annual meeting next month in New York City.

The course, “Office-Based Buprenorphine Treatment of Opioid-Dependent Patients,” will be offered on Wednesday, May 5, in Gramercy A on the second floor of the Hilton New York. The course runs from 8 a.m. to 5 p.m.

Physicians seeking certification must complete an eight-hour course conducted by one of four education providers jointly recognized by the Substance Abuse and Mental Health Services Administration and the Drug Enforcement Administration. APA is one of those providers.

Serving as course co-directors are Thomas Kosten, M.D., and Eric Strain, M.D. Faculty include Laura McNicholas, M.D., and Walter Ling, M.D.

More information about the course and course registration is available by e-mailing Elizabeth Rumsey at APA at .